The American Transportation Research Institute (ATRI) is seeking motor carriers to participate in research on rising insurance costs and strategies for managing risk.
Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patientsMultiple SAFEGUARD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback